SCHEMBL6027166

SCHEMBL6027166

NC(=O)C1NCCOc2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.44
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KEAP1 Q14145 1/20 0.37
SLC9A1 P19634 2/20 0.36
SSTR4 P31391 1/20 0.36
MAPK1 P28482 2/20 0.35
ITGB2 P05107 1/20 0.35
ICAM1 P05362 1/20 0.35
ITGAL P20701 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALOX5 P09917 1/20 0.35
SLC9A5 Q14940 1/20 0.34
SLC9A2 Q9UBY0 1/20 0.34
CYP2C9 P11712 1/20 0.34
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6027573 0.79 ATM (0.38) ATMKEAP1SLC9A1SSTR4ITGB2
SCHEMBL18027909 0.75 ITGB2 (0.41) KEAP1SSTR4ITGB2ICAM1ITGAL
SCHEMBL13091456 0.74 SMN1; SMN2 (0.43) KEAP1SMN1; SMN2DRD2DRD3
SCHEMBL31085324 0.72 ATM (0.47) ATMSLC9A1SSTR4MAPK1ITGB2
SCHEMBL29866456 0.72 TSHR (0.71) TSHRNPSR1GAASMN1; SMN2
SCHEMBL5392581 0.72 ATM (0.47) ATMSLC9A1SSTR4MAPK1ITGB2
SCHEMBL16303077 0.72 TSHR (0.71) TSHRNPSR1GAASMN1; SMN2
SCHEMBL5392565 0.72 ATM (0.47) ATMSLC9A1SSTR4MAPK1ITGB2
SCHEMBL31085320 0.72 ATM (0.47) ATMSLC9A1SSTR4MAPK1ITGB2
SCHEMBL30241060 0.72 ATM (0.47) ATMSLC9A1SSTR4MAPK1ITGB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1794997-B 2,3,4, 5-tetrahydrobenzo [ f ] [1,4] oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease HOFFMANN LA ROCHE 2010-05-12 CN disclosed
CN-1794997-A 2,3,4, 5-tetrahydrobenzo [ f ] [1,4] oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease HOFFMANN LA ROCHE (CH) 2006-06-28 CN disclosed
EP-1631296-A1 2,3,4,5-TETRAHYDROBENZO[F][1,4]OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2006-03-08 EP disclosed
WO-2004100958-A1 2, 3, 4, 5-TETRAHYDROBENZO[F][1, 4]OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2004-11-25 WO disclosed